(Boursier.com) – Erytech Pharma, a clinical-stage biopharmaceutical company that develops innovative therapies by encapsulating drugs in red blood cells (RBCs), announces its participation in investor conferences during the month of January and offers investors individual meetings. The group will be present at the LifeSci Partners – 11th Annual Corporate Access Event, which takes place from January 5 to 7, and then to the HC Wainwright BioConnect Virtual Conference which takes place from January 10 to 13. A webcast will be available for 90 days in the dedicated section of the group’s website on January 10 at 1 p.m.
© 2022 Boursier.com